قالب وردپرس درنا توس
Home / Health / Instant immunity? British scientists test drugs to prevent infection in people exposed to Covid-19 through rapid antibody enhancement — RT UK News

Instant immunity? British scientists test drugs to prevent infection in people exposed to Covid-19 through rapid antibody enhancement — RT UK News



British scientists have begun testing a new drug, which they claim can immediately develop immunity to Covid-19 and can save many lives as an emergency treatment for people exposed to the coronavirus.

“The advantage of this drug is that it can provide you with antibodies immediately,” Dr Catherine Houlihan, a virologist at the University Hospital of London’s NHS Trust (UCLH), told the Guardian that although the vaccine against the coronavirus will take about a month to be fully used.

The antibody therapy developed by UCLH in collaboration with AstraZeneca, a British vaccine manufacturer that has not yet approved Covid-19, may become “An exciting addition to the arsenal developed to fight this terrible virus,”

; Houlihan said.



Also on rt.com
The deal with AstraZeneca humiliated Sputnik V’s “immoral” attackers and cooperation should be encouraged – the funder of the Russian vaccine told RT


When the world is being vaccinated, it can be used in homes infected with the coronavirus as well as hospitals, nursing homes, universities and other places to help contain major epidemics.

Scientists believe that this drug based on the AstraZeneca AZD7442 long-acting antibody combination should be effective if it is provided to patients exposed to Covid-19 in the past eight days. According to reports, the immediate protection provided by the drug is expected to last six months to one year.

Trials of the therapy (which sounds too good at the moment to implement lock-in measures and new virus strains make headlines) began in early December at UCLH, other British hospitals, and about a hundred locations abroad. If the drug can prove its efficacy in tests and obtain approval from the British medical regulatory agency, the drug may be on the market as early as March or April.



Also on rt.com
Infectivity and variability: what we know about the new coronavirus strain – and how much you need to worry about


Do you like this story? share with friends!


Source link